Tag: Drug Prices

Maryland health regulator expands hospital price transparency efforts | FierceHealthcare

Maryland health regulator expands hospital price transparency efforts | FierceHealthcare

The Maryland Health Care Commission is expanding its price transparency initiative with tools aimed at getting consumers pushing for information about cost and quality directly from hospitals and doctors. Launched last fall, the MHCC’s “Wear the Cost” initiative provides prices at Maryland hospitals for common nonemergent procedures including hip replacements, knee replacements, hysterectomies and vaginal births to allow residents see the differences […]

Changing The Way Medicare Pays Doctors | Forbes

Changing The Way Medicare Pays Doctors | Forbes

Cutting the reward money But small physician practices and even larger groups with few Medicare patients may opt out of the new payment system.  CMS is also said it wants to experiment with excluding physicians in Medicare Advantage managed care plans from MIPs participation. As a result, reports the online journal Modern Healthcare, the amount […]

Trump’s Drug Plan Picks Up Momentum as Merck Lowers Some Prices | Bloomberg

Trump’s Drug Plan Picks Up Momentum as Merck Lowers Some Prices | Bloomberg

The Trump administration moved swiftly in the past 24 hours to implement pieces of its plan to bring down drug prices, preparing several significant steps as one of the biggest U.S. drugmakers said it would bring down the cost of some medicines. The Health and Human Services Department on Wednesday night submitted a proposal to […]

All-Payers Claims Databases May Increase Healthcare Price Transparency | Health Payer Intelligence

All-Payers Claims Databases May Increase Healthcare Price Transparency | Health Payer Intelligence

July 18, 2018 – Leveraging the data of all-payers claims databases (APCDs) could improve healthcare price transparency for consumers, according to testimony presented at a House Energy and Commerce Committee hearing. Jamie S. King, a professor at the USC Hastings College of Law, told the committee that APCDs could address price transparency challenges if stakeholders use […]

Blueprint to Lower Drug Prices could offer a way forward in fight against mushrooming costs | TheHill

Blueprint to Lower Drug Prices could offer a way forward in fight against mushrooming costs | TheHill

At a hearing before the Senate Finance Committee last month, Sen. Sherrod Brown (D-Ohio) asked Health and Human Services Secretary Alex Azar if he agreed “that there are scenarios where pharmaceutical companies increase the list price of their product and price-gouge consumers for no reason other than to increase their profit margin?” Secretary Azar’s response […]

CMS Proposes Drug Pricing, Price Transparency Changes for Medicare | healthpayerintelligence.com

CMS Proposes Drug Pricing, Price Transparency Changes for Medicare | healthpayerintelligence.com

July 13, 2018 – CMS has proposed a series of policy changes for Medicare that would promote prescription drug affordability within Medicare, and has also requested stakeholder comments about ways to improve price transparency for Medicare services. As part of changes to the 2019 Medicare Physician Fee Schedule (PFS), CMS would adopt a new pricing model […]

California shows Trump a thing or two about cutting drug costs | thepharmaletter

California shows Trump a thing or two about cutting drug costs | thepharmaletter

Apparently as a result of the law coming into effect, Switzerland’s Novartis (NOVN: VX) and Roche (ROG: SIX), as well as Gilead Sciences (Nasdaq: GILD) and Novo Nordisk (NOV: N), have either cancelled or reduced planned price increases for over 10 different products. … Lawyers for the industry said the proposal would dictate national healthcare […]

Why putting drug prices in ads is a bad idea | STAT

Why putting drug prices in ads is a bad idea | STAT

When the Trump administration released its blueprint for lowering drug prices a couple months ago, it floated a trial balloon: What if we required manufacturers to include drug prices in direct-to-consumer advertising? It’s unclear if the intent of doing that is to make prices more transparent to consumers, to “shame” manufacturers into lowering prices, to […]

Caving to pressure, Pfizer delays price hikes | BenefitsPRO

Caving to pressure, Pfizer delays price hikes | BenefitsPRO

Pfizer Inc. agreed to delay implementation of planned price increases for certain drugs a day after President Donald Trump launched an attack on the company, saying it should be “ashamed” of the move. Trump said on Tuesday evening that the New York-based company would be “rolling back price hikes” after he spoke with its chief […]

Drugmakers Cancel Price Hikes After California Law Takes Effect | Bloomberg

Drugmakers Cancel Price Hikes After California Law Takes Effect | Bloomberg

A handful of the world’s biggest drugmakers are canceling or reducing planned price increases in the U.S., following a new California drug pricing transparency law and continued political pressure over pharmaceutical costs. The California law, which began to take effect earlier this year, requires drugmakers to give insurers, governments and drug purchasers advance notice of […]